Clinical Trials in New York

Showing 4621-4640 of 22,668 trials

Laser Ablation of Papillary Thyroid Microcarcinoma

NCT04623801

The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.

Papillary Thyroid MicrocarcinomaThyroidThyroid Cancer

Memorial Sloan Kettering Cancer Center10 participantsStarted Oct 2020

New York, New York, United States

Active Not RecruitingPhase 1/2< 1 mile

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

The purpose of this Phase I study is to test the safety of different doses of specially prepared immune cells (called "T cells") collected from blood. The Investigators want to find a safe dose of these modified T cells for patients who have malignant pleural disease. They want to find out what effects these T cells have on the patient and the cancer (MPD). Phase 2 part of the study, the investigators will test the dose in combination with another drug, pembrolizumab, to see what effects the study treatment has on malignant pleural mesothelioma.

Malignant Pleural DiseaseMesotheliomaMetastases+2 more

Memorial Sloan Kettering Cancer Center113 participantsStarted May 2015

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +3 more locations

Laser Ablation of Papillary Thyroid Microcarcinoma

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Find Trials by Condition in New York

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

Improving Patient Prioritization During Hospital-homecare Transition

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Cognitive Remediation for Coordinated Specialty Care

Tislelizumab in People With Colorectal Cancer

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Acquired Dyslexia Modeling and Treatment

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Futibatinib in Patients With Specific FGFR Aberrations

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer